News
Pharmacy & healthcare news
Industry updates, regulation, and developments that matter to Indian pharmacies.
NPPA Fixes Retail Prices for 42 Pharmaceutical Formulations to Ensure Transparency in Pricing
NPPA has fixed retail prices for 42 new drug formulations to ensure uniformity in pricing and transparency in the pharma industry.
Feb 11, 2025
Telangana DCA Seizes Falsely Manufactured Tablets Sold as Nutraceuticals in Ramagundam
The Telangana Drugs Control Administration (DCA) seized falsely made RedFer-XT tablets in Ramagundam, Peddapalli district, which were illegally marketed as food products and nutraceuticals.
Feb 11, 2025
Concerns Over Substandard Medicines Raised in Rajya Sabha as Opposition Calls for Stricter Regulations
The issue of substandard medicines available for sale in India came to the fore in the Rajya Sabha today by Deputy Leader of Opposition Pramod Tiwari, who called for greater awareness and better quality controls in drug production. Drawing upon reports by Drugs Controller General of India (DCGI), he sounded an alert that more than 50 medicines, including those that are life-saving, have failed quality tests, posing a serious threat to public health.
Feb 10, 2025
CSIR-NIIST Develops Technology to Convert Biomedical Waste into Soil Additives
The Council of Scientific and Industrial Research-National Institute for Interdisciplinary Science and Technology (CSIR-NIIST) has developed an innovative technology to convert pathogenic biomedical waste into soil additives, offering a safe, cost-effective, and eco-friendly alternative to traditional incineration methods.
Feb 10, 2025
DGFT Amends Standard Input Output Norms for Erythromycin Stearate Tablets
The Directorate General of Foreign Trade (DGFT) has announced amendments to the Standard Input Output Norms (SION) for the export of erythromycin stearate tablets. The revision, detailed in a Public Notice issued by DGFT Director General Santosh Kumar Sarangi, was published in the Gazette of India Extraordinary and is expected to streamline export processes for pharmaceutical manufacturers.
Feb 10, 2025
EMA Establishes Regular Procedure for Scientific Advice on High-Risk Medical Devices
The European Medicines Agency (EMA), in collaboration with the European Commission, has introduced a regular procedure for manufacturers of high-risk medical devices to obtain scientific advice on their clinical development strategies.
Feb 10, 2025
Health Ministry to Set Up Expert Panel to Review Adverse Events Linked to Medical Devices
The Health Ministry of India has announced plans to establish an expert committee focused on monitoring and analyzing adverse events related to medical devices, with the aim of enhancing patient safety. The panel will assess risks associated with devices like X-ray machines, implants, surgical instruments, and in-vitro diagnostic reagents, and recommend measures to address safety concerns.
Feb 10, 2025
Spike in GBS Cases in Pune Linked to Contaminated Water Supply
A surge in Guillain-Barre Syndrome (GBS) cases in Pune has alarmed residents, with many suspecting contaminated water supplies as the source of the outbreak.
Feb 10, 2025
Govt Expands Duty-Free Access to Life-Saving Drugs in Union Budget 2025-26
The Union Budget 2025-26, presented by Finance Minister Nirmala Sitharaman, has rolled out substantial customs duty exemptions and trade facilitation measures to spur domestic manufacturing, support healthcare, and boost exports.
Feb 1, 2025
India's Ease of Doing Business Gets a Boost as Budget 2025 Introduces Jan Vishwas 2.0
The Union Budget 2025-26 has announced the Jan Vishwas Bill 2.0, which looks to decriminalize more than 100 outdated legal provisions with a view to ease doing business in India.
Feb 1, 2025
Drug Safety Alert: IPC Issues Warning Regarding Adverse Effects By Amphotericin B and Carbimazole
As part of its latest drug safety alert in November, the Indian Pharmacopoeia Commission (IPC) cautioned about the possibility of serious adverse drug reactions (ADRs) with the use of amphotericin B and carbimazole to warn healthcare professionals on their use.Key Findings:
Dec 6, 2024
FDA Approves Accelerated Approval of Zenocutuzumab-zbco for Advanced Lung and Pancreatic Cancers
The U.S. Food and Drug Administration (FDA) approved accelerated approval of Zenocutuzumab-zbco (sold under the brand name Bizengri by Merus N.V.) for the treatment of advanced non-small cell lung cancer (NSCLC) and pancreatic adenocarcinoma harboring NRG1 gene fusions.
Dec 6, 2024
HPV Vaccine Excluded from National Immunization Drive, Emphasis on Cancer Screening
It is in a major statement during a session in the Lok Sabha, when Union Health Minister J.P. Nadda said that the HPV vaccine is of extreme importance in order to prevent cervical cancer; however, it has yet to be added to the Universal Immunization Programme (UIP).
Dec 6, 2024
Stop Using OTC Creams Without Medical Advice, Experts Warn at KGMU
Experts have warned against the use of over-the-counter creams for fungal infections, itching, and rashes without proper medical consultation in a recent dermatology awareness program held at King George's Medical University in Lucknow.
Dec 6, 2024
Surat: Fake Medical Degree Racket Unraveled; 13 Including 10 Fake Doctors Held
In a major crackdown, Surat police have busted a fraudulent operation selling fake Bachelor of Electro-Homeopathy Medicine and Surgery (BEMS) degrees, leading to the arrest of 13 individuals, including 10 quacks who were illegally running clinics and prescribing allopathic medicines.
Dec 6, 2024
Kanpur Market Flooded with Fake Medicines Containing Chalk and Clay: Drug Department's Shocking Discovery
Kanpur has been rocked by alarming revelations of fake and substandard medicines being sold in its market. A laboratory analysis conducted by the Uttar Pradesh Drug Department over the last 10 months uncovered that several medications, including antibiotics and common remedies for gas, fever, and urinary infections, contained harmful substances like chalk and clay.Key Findings from the Drug Department's Report:
Dec 5, 2024
PMBI Blacklists Six Drug Suppliers in Five Years for Failing Quality Standards
Six Suppliers Barred for Non-Compliance with Quality Standardsthe Pharmaceuticals & Medical Devices Bureau of India (PMBI), the central body that regulates drug supply to Jan Aushadhi Kendras (JAKs), has blacklisted six pharmaceutical suppliers over the last five years for failure to meet the prescribed quality standards. In this context, it will be a safe and high-quality medicine for all.
Dec 4, 2024
WHO Approves First Single-Dose Medicine for Relapsing Malaria
In a monumental step toward combating relapsing malaria, the World Health Organization (WHO) has granted prequalification to tafenoquine, the first-ever single-dose medicine aimed at preventing relapses of Plasmodium vivax (P. vivax) malaria.
Dec 4, 2024
Gujarat IMA Opposes 'Mixopathy' Proposal, Says There Will Be Huge Health Risks
The Gujarat branch of the Indian Medical Association (IMA) has strongly opposed the decision of the health department in Gujarat, which is proposing that Ayurvedic doctors be allowed to practice allopathy under 'mixopathy.'
Dec 31, 2024
AB-PMJAY Has Relieved Cancer Patients of Financial Burden, Says PM Modi
Prime Minister Narendra Modi, in the 117th episode of his "Mann Ki Baat" broadcast, highlighted the transformative impact of the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) on the accessibility and affordability of cancer treatment. He also highlighted India's success in fighting malaria, which has been recognized globally.
Dec 30, 2024
FDA Approves Lenacapavir for HIV Prevention, Hailed as 'Breakthrough of the Year'
The US Food and Drug Administration has finally approved Lenacapavir. This is a new injectable HIV drug, providing protection for up to six months in a single dose.
Dec 30, 2024
Mankind Pharma Collaborates with Innovent Biologics to Launch Sintilimab in India Date: 30 December 2024
As part of a strategic effort to address the ever-increasing cancer burden in India, Mankind Pharma has partnered with Innovent Biologics to gain exclusive rights to market and sell Sintilimab, an innovative PD-1 immunotherapy.
Dec 30, 2024
Massive Counterfeit Drug Racket Busted: Ineffective Medicines Sold in Government Hospitals
The authorities have busted a massive counterfeit drug racket that revealed how government hospitals had been sold ineffective medicines, which lacked Active Pharmaceutical Ingredients (APIs).
Dec 30, 2024
Kerala Leads India’s Battle Against AMR with Comprehensive New Report
Thiruvananthapuram: Kerala released its 2023 antibiogram report that marks the third consecutive year of scheduled AMR surveillance.
Dec 3, 2024
Ready to simplify your pharmacy?
Start your free 7-day trial or book a personalised demo today.